# Iridex Corp (IRIX)

> Iridex Corp (IRIX) trades at $0.4450 (-4.57%) as of 7:57:21 PM EST on Nov 20, 2026, -41.63% over the past month. Market cap is $7.92M, with 1.6 days to cover in short interest.

Canonical: https://massive.com/quote/irix
Data as of: 2026-11-21T00:57:21.009Z (15-minute delayed)
Source: Massive (https://massive.com/docs/llms.txt)

## Price

**$0.4450** -0.02 (-4.57%)
At close · 15-minute delayed
Nasdaq · usd

After hours: **$0.4345** -0.01 (-2.36%)
As of 7:57:21 PM EST on Nov 20, 2026 · After hours

## Stock performance

How Iridex Corp (IRIX) stock has performed from one day to one year, with its 52-week range.

| Period | Return |
| --- | --- |
| 1D | -4.58% |
| 1W | -35.51% |
| 1M | -41.63% |
| YTD | -60.97% |
| 1Y | -51.42% |
| 52-wk range | $0.43 – $1.65 |

From daily closes through Nov 20, 2026.

## Key statistics

Today's trading snapshot for IRIX: day range, open, previous close, volume and market cap.

| Measure | Value |
| --- | --- |
| Day range | $0.43 – $0.48 |
| Open | $0.48 |
| Prev close | $0.47 |
| Volume | 49.42K |
| Market cap | $7.92M |
| Shares out | 17.81M |

## Valuation and profitability ratios

Valuation and profitability ratios for Iridex Corp: P/E, P/S, P/B, ROE and more.

| Measure | Value |
| --- | --- |
| P/E | — |
| P/S | 0.16 |
| P/B | 2.98 |
| P/FCF | — |
| ROE | -128.5% |
| ROA | -11.5% |
| Debt/Equity | 1.46 |
| Div yield | 0.00% |

As of Nov 20, 2026

## Insider trading

[Iridex Corp (IRIX) insider trading](https://massive.com/quote/irix/insider-trading.md): open-market Form 4 buys and sells by Iridex Corp insiders over the last 12 months.

## 8-K filings

Material corporate events Iridex Corp has disclosed to the SEC on Form 8-K.

- Nov 17, 2026 · [Quarterly earnings](https://massive.com/quote/sec-filings/8-k/earnings-releases.md)
  “On November 17, 2026, IRIDEX Corporation issued a press release discussing its financial results for its third fiscal quarter ended October 3, 2026. The press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.”
- Sep 2, 2026 · [Listing deficiency notice](https://massive.com/quote/sec-filings/8-k/delisting-notices.md)
  “On August 27, 2026, IRIDEX Corporation (the "Company") received a notification of non-compliance (the "Notice") from Nasdaq's Listing Qualifications Department ... notifying the Company that, for the last 30 consecutive business days, the minimum bid price of the Company's common stock had been below the $1.00 per share minimum requirement for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2).”
- Jul 16, 2026 · Annual meeting results
  “Based on the votes set forth above, each director nominee was duly elected to serve until the 2027 Annual Meeting of Stockholders or until his or her respective successor is duly elected and qualified or until his or her earlier death, resignation or removal. The director nominees elected were Nick Chen, Beverly A. Huss, Patrick Mercer, William Moore, and Scott Shuda.”
- Jun 18, 2026 · Shareholder meeting notice
  “The Annual Meeting will reconvene at 8:00 a.m., Pacific Time, on Friday, July 10, 2026. The Annual Meeting will still be held in person at the Company's principal executive offices located at 1212 Terra Bella Avenue, Mountain View, California 94043. The record date for stockholders entitled to vote at the Annual Meeting remains April 17, 2026.”
- Mar 13, 2026 · Lease agreement
  “On March 9, 2026, IRIDEX Corporation (the "Company") and SFIII Hellyer, LLC and SFIII FOS Hellyer Holding, LLC (the "Landlord") entered into a triple net lease (the "Lease") pursuant to which the Company will lease office space located at 5215 Hellyer Avenue in San Jose, California (the "Leased Space") as the Company's new corporate headquarters. The Leased Space consists of approximately 30,784 square feet. The Lease term is anticipated to commence on July 1, 2026 or such earlier date as the Company begins occupancy of the Leased Space for its business operations. The term of the Lease is 90 months from the commencement date.”

## IRIX short interest

How heavily IRIX is shorted: shares short, days to cover and average daily volume.

| Measure | Value |
| --- | --- |
| Days to cover | 1.6 |
| Short interest | 39.42K |
| Avg volume | 24.98K |

As of Oct 30, 2026 · reported to FINRA twice monthly.

## IRIX news

The latest news and headlines about Iridex Corp (IRIX).

- [Iridex Announces the Publication of Two-Year Independent Study Supporting Benefits of MicroPulse® Technology for Early to Advanced Glaucoma](https://www.globenewswire.com/news-release/2026/10/12/3378782/0/en/iridex-announces-the-publication-of-two-year-independent-study-supporting-benefits-of-micropulse-technology-for-early-to-advanced-glaucoma.html) · GlobeNewswire Inc. · Oct 12, 2026 · positive sentiment
- [Iridex Announces Plans to Relocate Headquarters](https://www.globenewswire.com/news-release/2026/02/02/3230108/0/en/Iridex-Announces-Plans-to-Relocate-Headquarters.html) · GlobeNewswire Inc. · Feb 2, 2026 · positive sentiment
- [Iridex Announces the Publication of an Independent Study Demonstrating Safe and Effective Retreatment with Transscleral Laser Treatment Using MicroPulse® Technology in Glaucoma Management](https://www.globenewswire.com/news-release/2025/12/11/3203755/0/en/Iridex-Announces-the-Publication-of-an-Independent-Study-Demonstrating-Safe-and-Effective-Retreatment-with-Transscleral-Laser-Treatment-Using-MicroPulse-Technology-in-Glaucoma-Mana.html) · GlobeNewswire Inc. · Dec 11, 2025 · positive sentiment
- [Iridex Reports 7 Percent Q2 Revenue Gain](https://www.fool.com/data-news/2025/08/13/iridex-reports-7-percent-q2-revenue-gain/?source=iedfolrf0000001) · The Motley Fool · Aug 12, 2025 · neutral sentiment
- [Iridex Comments on Recent Stock Price Volatility](https://www.globenewswire.com/news-release/2025/03/14/3042867/0/en/Iridex-Comments-on-Recent-Stock-Price-Volatility.html) · GlobeNewswire Inc. · Mar 14, 2025 · neutral sentiment

## About Iridex Corp

IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

| Measure | Value |
| --- | --- |
| Exchange | Nasdaq |
| Market | stocks |
| Type | CS |
| Currency | USD |
| Industry | ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS |
| Employees | 108 |
| Listed | Feb 16, 1996 |

[Company website](https://www.iridex.com)

## FAQ

### What is the Iridex Corp (IRIX) stock price today?

Iridex Corp (IRIX) is trading at $0.4450 (-4.57% on the day) as of 7:57:21 PM EST on Nov 20, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

### What is Iridex Corp?

IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases.

### What is the short interest in IRIX?

As of Oct 30, 2026, IRIX has 39.42K shares short and 1.6 days to cover.

### What exchange is IRIX listed on?

Iridex Corp (IRIX) trades on Nasdaq in USD, in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS industry.

## Live data

Prices here are 15-minute delayed. For real-time IRIX quotes and the full history behind this page, use the Massive API or MCP server:

- `GET https://api.massive.com/v3/snapshot?ticker.any_of=IRIX`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [Iridex Corp (IRIX) insider trading](https://massive.com/quote/irix/insider-trading.md)
- [SEC 8-K events](https://massive.com/quote/sec-filings/8-k.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms
